The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997
AIDSPublished 1 July 1999
Amanda Mocroft, Simon Barry, Caroline Sabin, Alessandro Cozzi Lepri, Sabine Kinloch, Anthony Drinkwater
Citations51
SJR quartileQ1
SJR score1.21
SNIP0.90
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Admissions to hospital began falling before the introduction of combination therapy and declined strikingly during 1996 and 1997 following the introductionof highly active antiretroviral therapy.
Abstract
Admissions to hospital began falling before the introduction of combination therapy and declined strikingly during 1996 and 1997 following the introduction of highly active antiretroviral therapy. These results have important implications for future allocation of resources and for patient management.
Keywords
Medicine
New England Journal of MedicineDeclining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
9,465 Citations1998Frank J. Palella, Kathleen M. Delaney +6 more
The recent declines in morbidity and mortality due to AIDS are attributable to the use of more intensive antiretroviral therapies.
New England Journal of MedicineA Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
2,666 Citations1997Scott M. Hammer, Kathleen Squires +14 more
Treatment with indinavir, zidovudine, and lamivudine as compared with zidvudine and lam ivudine alone significantly slows the progression of HIV-1 disease in patients with 200 CD4 cells or fewer per cubic millimeter and prior exposure to zidavudine.
New England Journal of MedicineTreatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
1,900 Citations1997Roy M. Gulick, John W. Mellors +14 more
In most HIV-infected patients with prior antiretroviral therapy, the combination of indinavir, zidovudine, and lamivudine reduces levels of HIV RNA to less than 500 copies per milliliter for as long as one year.
The LancetChanging patterns of mortality across Europe in patients infected with HIV-1
1,284 Citations1998Amanda Mocroft, Stefano Vella +9 more
Death rates across Europe among patients infected with HIV-1 have been falling since September, 1995, and at the beginning of 1998 were less than a fifth of their previous level.
New England Journal of MedicineA Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter
1,088 Citations1996Scott M. Hammer, David Katzenstein +10 more
Antiretroviral therapy can improve survival in patients with 200 to 500 CD4 cells per cubic millimeter and is superior to treatment with zidovudine alone, although the benefits were limited to those without previous treatment.
BMJImpact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study
624 Citations1997Matthias Egger, Bernard Hirschel +8 more
The introduction of antiretroviral combination therapies outside the selected patient groups included in clinical trials has led to comparable reductions in disease progression and mortality in Switzerland.
The LancetRandomised placebo-controlled trial of ritonavir in advanced HIV-1 disease
540 Citations1998D. William Cameron, Margo Heath‐Chiozzi +9 more
Although earlier intervention with combination therapy may provide much more effective treatment, ritonavir in patients with advanced disease and extensive previous antiretroviral use is safe and effective, lowers the risk of AIDS complications, and prolongs survival.
The LancetDelta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals
515 Citations1996JH Darbyshire
Initiation of treatment with combinations of AZT plus ddI or ddC prolongs life and delays disease progression compared with AZT alone, and the addition of ddI to participants already treated withAZT improves survival, although the benefit appears less.
New England Journal of MedicinePhysicians' Experience with the Acquired Immunodeficiency Syndrome as a Factor in Patients' Survival
462 Citations1996Mari M. Kitahata, Thomas D. Koepsell +4 more
The experience of primary care physicians in the management of AIDS is significantly associated with survival among their patients.
AIDSImpact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres
363 Citations1997Y Mouton, S. Alfandari +10 more
This study supports the extensive use of HAART in HIV-infected patients and shows a clear benefit to early HAART with a drop in hospitalization days, new AIDS cases, and deaths.
Annals of Internal MedicineNatural History of Opportunistic Disease in an HIV-Infected Urban Clinical Cohort
285 Citations1996Richard D. Moore, Richard E. Chaisson
The contemporary natural history of opportunistic disease in an urban population may be particularly relevant given the recent trends toward higher rates of HIV infection and the acquired immunodeficiency syndrome (AIDS) in women, members of racial and ethnic minority groups, and injection drug users.
The LancetRandomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial
247 Citations1997CAESAR Coordinating Committee, [Unknown], Study group members AMC, : +2 more
This dissertation aims to provide a history of web exceptionalism from 1989 to 2002, a period chosen in order to explore its roots as well as specific cases up to and including the year in which descriptions of “Web 2.0” began to circulate.
The LancetBritish HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals
219 Citations1997BG Gazzard, GJ Moyle +15 more
Broad principles have a wide consensus amongst HIV-treating physicians in the UK that treatment should be offered before substantial immunodeficiency ensues and switches in therapy should involve substitution or addition of at least two new agents.
New England Journal of MedicineZidovudine Alone or in Combination with Didanosine or Zalcitabine in HIV-Infected Patients with the Acquired Immunodeficiency Syndrome or Fewer Than 200 CD4 Cells per Cubic Millimeter
175 Citations1996Louis D. Saravolatz, Dean L. Winslow +10 more
Treatment with zidovudine plus didanosine was associated with a relative risk of disease progression or death of 0.86 (95 percent confidence interval, 0.71 to 1.03), and treatment with zagavirine plus zalcitabine was as...
JAMAThe Relation Between Hospital Experience and In-Hospital Mortality for Patients With AIDS-Related PCP
142 Citations1989Charles L. Bennett
The findings suggest that policymakers should consider three options: creating regional AIDS centers, implementing policies that promote a rapid but carefully monitored increase in experience of low-volume hospitals with human immunodeficiency virus-infected individuals, or providing highly focused educational efforts at low-AIDS-experience facilities.
Annals of Internal MedicineCombination Therapy with Zidovudine and Didanosine Compared with Zidovudine Alone in HIV-1 Infection
133 Citations1993Ann C. Collier, Robert W. Coombs +11 more
It is found that this combination therapy is well tolerated and is associated with enhanced in vivo activity as shown by higher and more prolonged increases of CD4+ cell counts, with more frequent decreases in plasma HIV-1 RNA titers, and with more stable hematologic measurements than zidovudine therapy alone.
AIDSThe impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infection
127 Citations1999Simon Paul, Holly M. Gilbert +3 more
Since the introduction of potent antiretroviral therapy, a significant decrease in the incidence of hospital admission and opportunistic infections has occurred and there has been a doubling of the median CD4 cell count of inpatients.
Archives of Internal MedicineDistribution of CD4+ T Lymphocytes at Diagnosis of Acquired Immunodeficiency Syndrome—Defining and Other Human Immunodeficiency Virus—Related Illnesses
111 Citations1995Debra L. Hanson
Observations support the need for continued CD4 + cell count monitoring below a level of 0.20 ×10 9 /L as a guide to diagnosis and medical management of HIV-infected persons.
BMJSurvival differences in European patients with AIDS, 1979–89
97 Citations1994Jens Lundgren, C Pedersen +7 more
Improved survival in recent years was observed for patients with a variety of manifestations used to define AIDS but was significant only for patients diagnosed with Pneumocystis carinii pneumonia, and survival seems to vary within Europe, being shorter in southern than central and northern Europe.
Archives of Internal MedicineDistribution of CD4+ T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses. The Adult and Adolescent Spectrum of HIV Disease Project Group
94 Citations1995Debra L. Hanson
Observations support the need for continued CD4+ cell count monitoring below a level of 0.20 x 10(9)/L as a guide to diagnosis and medical management of HIV-infected persons.
Archives of Internal MedicineThe Incidence of AIDS-Defining Illnesses in 4883 Patients With Human Immunodeficiency Virus Infection
73 Citations1998Amanda Mocroft
This study provides important information about the risk of AIDS-defining illnesses at lower CD4 lymphocyte counts, enabling disease-specific prophylaxis to be targeted at the most appropriate population.
Journal of Acquired Immune Deficiency Syndromes & Human RetrovirologyCosts of HIV+/AIDS at CD4+ Counts Disease Stages Based on Treatment Protocols
72 Citations1996Carol Brignoli Gable, Jonothan C. Tierce +3 more
The estimates are consistent with decreasing costs of HIV+/AIDS due to a reduction in the average length of stay and frequency of hospitalizations as well as to replacement of inpatient care by outpatient services.
BMJSurvival after diagnosis of AIDS: a prospective observational study of 2625 patients
61 Citations1997Amanda Mocroft, M Youle +5 more
Archives of Internal MedicinePneumocystis Prophylaxis and Survival in Patients With Advanced Human Immunodeficiency Virus Infection Treated With Zidovudine
59 Citations1992Richard E. Chaisson
Pneumocystis cariniipneumonia during follow-up was strongly associated with death when controlling for other factors, and consistent use of each was associated with improved survival.
JAMALong-term Survival of Patients With AIDS, Pneumocystis carinii Pneumonia, and Respiratory Failure
45 Citations1991Yaakov Friedman
The long-term prognosis for patients with the acquired immunodeficiency syndrome, P carinii pneumonia, and acute respiratory failure is now substantially better than anticipated.
Journal of Acquired Immune Deficiency Syndromes & Human RetrovirologyRapid Change in the Use of Antiretroviral Agents and Improvement in a Population of HIV-Infected Patients: France, 1995 to 1997
44 Citations1998Rosemary Dray‐Spira, Catherine Marimoutou +3 more
Over this 3-year period, physicians prescribed antiretroviral treatments more and more frequently, and triple combination therapy with PI is now common practice in France.
AIDSChanging use of hospital services and costs at a London AIDS referral centre, 1983–1989
43 Citations1994Eduard J. Beck, Jo Kennelly +7 more
The shift from an inpatient- to an outpatient-based service has resulted in fewer patients being investigated and treated in hospital and more as outpatients, while outpatient-related costs have increased, increasing the overall contribution of drug-costs to the total cost over time.
AIDSImproved survival from diagnosis of AIDS in adult cases in the United Kingdom and bias due to reporting delays
39 Citations1993S. Elizabeth Whitmore-Overton, Hilary E. Tillett +2 more
Average survival for very recent cohorts tends to be underestimated because longer survival has been observed in patients for whom there is a longer delay between AIDS diagnosis and report to the Communicable Disease Surveillance Centre.
Archives of Internal MedicinePneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group
20 Citations1992Richard E. Chaisson
Prophylaxis with trimethoprim-sulfamethoxazole and aerosol pentamidine both were associated with a decreased likelihood of PCP, and consistent use of each was associated with improved survival.
JAMAThe relation between hospital experience and in-hospital mortality for patients with AIDS-related PCP
20 Citations1989Cherie Bennett
AIDSHospital costs of treating haetnophilic patients infected with HIV
19 Citations1995Joanne M. Kennelly, Keith Tolley +4 more
The HIV-related cost estimates can be used for the planning of current and future hospital-based care in the National Health Service in the United Kingdom.
Journal of Epidemiology & Community HealthPatterns of hospital care for patients with HIV infection and AIDS.
19 Citations1993Margaret Johnson, C Shergold +3 more
The data indicate less intensive use of inpatient care by AIDS patients over time, and hence the apparent ability to manage an increasing AIDS patient workload without a comparable increase in occupied bed days.